Wave Life Sciences (WVE) Receivables (2014 - 2026)

Wave Life Sciences (WVE) has 11 years of Receivables data on file, last reported at $888000.0 in Q2 2026.

• Quarterly Receivables fell 45.08% year-over-year to $888000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $888000.0 (down 45.08% YoY) and the FY2025 annual result came in at $1.3 million, down 10.27% from the prior year.
• Receivables eased to $888000.0 in Q2 2026, from $1.3 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $21.1 million in Q4 2023 to a low of $888000.0 in Q2 2026.
• A 4-year average of $5.6 million and a median of $1.5 million in 2024 frame the typical range for Receivables.
• Annual changes were most pronounced in 2024 — Receivables slumped 93.26% — and 2025, when it advanced 25.35%.
• Tracing WVE's Receivables over 4 years: stood at $21.1 million in 2023, then tumbled by 93.26% to $1.4 million in 2024, then slipped by 10.27% to $1.3 million in 2025, then plunged by 30.41% to $888000.0 in 2026.
• The last three Receivables figures came in at $888000.0 (Q2 2026), $1.3 million (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.